AI drug discovery platform

BRIEF: InSilico gets CSRC nod for Hong Kong IPO

AI drug discovery platform InSilico Medicine Cayman TopCo has been approved by China’s securities watchdog for a Hong Kong IPO, clearing a key hurdle in its stalled listing. According to…

Recent Articles

RELATED ARTICLES

  1. XtalPi scores landmark deal
    XtalPi scores landmark deal for AI drug discovery
    2228.HK
  2. BRIEF: Tianyu Semiconductor gets CSRC nod for Hong Kong IPO
  3. BRIEF: Lens Technology’s Hong Kong IPO gets nod from CSRC
  4. BRIEF: EV maker Seres gets CSRC nod for Hong Kong listing
    601127.SHG
  5. BRIEF: Fibocom gets China’s regulatory nod for Hong Kong IPO
    300638.SHE
  6. BRIEF: Nsing Technologies gets China’s regulatory nod for Hong Kong listing
    300077.SHE
  7. BRIEF: WeRide, Pony AI approved by CSRC to list in Hong Kong
    WRD.US
    PONY.US
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva